Human Pluripotent Stem Cell-Derived Endothelial Cells in Disease Modeling and Drug Screening

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Endothelial Cell Biology

Background:

• Endothelial dysfunction is central to cardiovascular diseases, the leading global cause of death.
• Current models like animal studies have limitations in replicating human conditions and raise ethical concerns.
• Human primary endothelial cells are limited by availability and reproducibility issues.

Purpose of the Study:

• To present methods for evaluating the phenotypic and functional properties of human induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs).
• To validate hiPSC-ECs as a reliable model for cardiovascular disease research and drug screening.
• To establish the potential of hiPSC-ECs as an unlimited cell source for endothelial cell research.

Main Methods:

• Immunohistochemistry and Fluorescence-Activated Cell Sorting (FACS) were used to assess endothelial markers, morphology, and differentiation efficacy.
• Functional assays, including wound healing and 3D spheroid-based angiogenesis, were performed to evaluate cell behavior.
• High-content screening approaches were employed to analyze endothelial cell phenotype.

Main Results:

• Immunohistochemistry and FACS confirmed successful differentiation and validated endothelial characteristics of hiPSC-ECs.
• Functional assays demonstrated that hiPSC-ECs exhibit behaviors similar to native endothelial cells, including migration and angiogenesis.
• High-content screening provided a comprehensive analysis of the endothelial phenotype, supporting their utility.

Conclusions:

• hiPSC-ECs provide a reproducible and scalable alternative to traditional endothelial cell models.
• The evaluated methods confirm the suitability of hiPSC-ECs for modeling cardiovascular diseases.
• hiPSC-ECs hold significant promise for advancing cardiovascular research and accelerating drug development.